1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow MEDI9197: new trials by email Literature Review of MEDI9197 trials Research Report on MEDI9197
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors MEDI9197, durvalumab - Solid Tumors, CTCL | Phase 1 | Terminated | MedImmune LLC | 53 | 2015-11-04 | 2018-12-19 |
Neoplasms (1)
MedImmune LLC (1)
Canada (1) · France (1) · United States (1)